Intuitive Surgical (NASDAQ:ISRG) Given “Outperform” Rating at Royal Bank Of Canada

Royal Bank Of Canada reissued their outperform rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a report released on Tuesday,Benzinga reports. The firm currently has a $615.00 price objective on the medical equipment provider’s stock.

ISRG has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating and cut their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Piper Sandler reissued an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a report on Tuesday, July 8th. Finally, UBS Group lifted their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $479.20 on Tuesday. The company has a market capitalization of $171.78 billion, a P/E ratio of 66.83, a P/E/G ratio of 5.04 and a beta of 1.59. The business has a fifty day simple moving average of $506.84 and a two-hundred day simple moving average of $523.82. Intuitive Surgical has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the prior year, the firm earned $1.78 EPS. The business’s revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 7,893 shares of the firm’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the sale, the insider owned 13,187 shares in the company, valued at $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock valued at $7,896,972 in the last quarter. Insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

Hedge funds have recently bought and sold shares of the company. Castleark Management LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after buying an additional 2,990 shares during the period. Arlington Trust Co LLC grew its position in Intuitive Surgical by 34.5% during the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock worth $369,000 after acquiring an additional 191 shares during the last quarter. Aveo Capital Partners LLC increased its stake in Intuitive Surgical by 37.4% in the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider’s stock worth $390,000 after purchasing an additional 198 shares during the period. Aaron Wealth Advisors LLC lifted its position in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock valued at $1,243,000 after purchasing an additional 78 shares during the last quarter. Finally, Longbow Finance SA lifted its position in Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock valued at $9,756,000 after purchasing an additional 11,209 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.